Multiple Sclerosis

GAITHERSBURG, Md., United States – May 2026 Neuraly Inc. has announced that the first patient has been dosed in...

VALENCIA, California, April 30, 2026 SetPoint Medical announced the first patients enrolled in a pilot clinical study evaluating its...

PARIS, April 24, 2026 Sanofi has achieved a significant regulatory milestone as the European Medicines Agency’s Committee for Medicinal...

NESS ZIONA, Israel, April 16, 2026 Mapi Pharma Ltd. has announced new clinical findings demonstrating that its Glatiramer Acetate...

BASEL, Switzerland, April 13, 2026 Roche has announced that its Elecsys® Neurofilament Light Chain (NfL) blood test has received...

TORONTO, April 1, 2026 Quantum BioPharma Ltd. announced the submission of an Investigational New Drug (IND) application to the...